Skip to content

Does Longitudinal Nursing Follow-up Improve Smoking Cessation in Patients Referred for COPD Screening

Does Longitudinal Nursing Follow-up Improve Smoking Cessation in Patients With Chronic Obstructive Pulmonary Disease (COPD) Screening

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05577767
Acronym
BPCO
Enrollment
233
Registered
2022-10-13
Start date
2020-09-11
Completion date
2026-09-11
Last updated
2026-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD, Nurse's Role

Brief summary

a monocentric study to evaluate the efficacy of a longitudinal nursing follow up in smoking cessation in patients screened for Chronic obstructive pulmonary disease (COPD).

Detailed description

The challenges to limit the occurrence of COPD are early detection, the fight against smoking and smoking and addictions (e.g. Cannabis), as well as the fight against environmental exposures. we proposed to evaluate if a longitudinal nursing follow-up at 3 months, 6 months and one year, in patients coming to screening for COPD. Cessation of respiratory toxics is the most effective intervention in stopping the progression of COPD.

Interventions

None listed

Sponsors

Centre Hospitalier de Valence
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Smoking patients screened for COPD between 35 years old 65 years old * Read, write and understand the French language * Patient affiliated to a social security system * Written and signed informed consent

Exclusion criteria

* Patients with a diagnosis of respiratory diseases * Patients receiving inhaled respiratory therapy * Persons unable to perform spirometry * Pregnant women * Refusal to participate in research * Patient under guardianship, deprived of liberty, safeguard of justice

Design outcomes

Primary

MeasureTime frameDescription
number of cigarettes or other toxic substancesup to 1 yearper day

Countries

France

Contacts

PRINCIPAL_INVESTIGATORGilles RIVAL, MD

CH VALENCE

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 19, 2026